Parkinson's Disease in a Patient with 22q11.2 Deletion Syndrome: The Relevance of Detecting Mosaicisms by Means of Cell-By-Cell Evaluation Techniques

Perandones C^1*, Farini VL², Pellene LA³, Sáenz Farret M³, Cuevas SM³, Micheli FE³ and Radrizzani M²

¹Scientific and Technological Coordination Unit of the ANLIS Directorate, National Administration of Laboratories and Institutes of Health, Argentina

²Laboratory of Neuro and Molecular Cytogenetic (CONICET), School of Sciences and Technology, CESyMA, National University of San Martin, Buenos Aires, Argentina

³Parkinson’s Disease and Movement Disorders Program, Hospital de Clínicas, University of Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina